Psy130 - The Relationship Between Disease Type and Conditional or Exceptional Approval by Ema for Orphan Drugs in 2017

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2704
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Identification of Approval Conditions for Orphan Drugs for Neurological Disorders by the Japanese Regulatory Agency

Expert Opinion on Orphan Drugs
ToxicologyPharmaceuticsPharmacologyHealth Policy
2018English

Php220 - Old Drugs Turned New for Ultra Orphan Disease: A Challenge for Payers or for the Industry?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Conditional Relationship Between Inequality and Development

PS - Political Science and Politics
SociologyPolitical Science
2009English

Comparison of Recent Hta Appraisals of Orphan Drugs by Nice, SMC and Has in 2015-2017

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Relationship Between the Price Differences in Orphan Drugs With More Than One Benefit Assessment in Amnog and the Potential Influencing Factors

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Hta Studies on Orphan Drugs by Rebratsxmembers

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Conditional Approval: Japan Lowers the Bar for Regenerative Medicine Products

Cell Stem Cell
Molecular MedicineGeneticsCell Biology
2015English

Psy60 - Orphan Versus Ultra-Orphan Drugs Prices in England

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Psy75 - Is Disease Area a Determinant of Orphan Drugs Prices？

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy